|

Stem Cell Mobilization Therapy Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since May 2026

Also known as: Chemomobilization, Hematopoietic Stem Cell Mobilization, Mobilization Therapy, Stem-cell mobilization

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • Eastern Cooperative Oncology Group1
  • City of Hope Medical Center1

Indications

  • Cancer2
  • Follicular Helper T-Cell Lymphoma, Angioimmunoblastic-Type1
  • Follicular Helper T-Cell Lymphoma1
  • Chronic Myeloid Leukemia, BCR-ABL1 Positive1
  • Anaplastic Large Cell Lymphoma, ALK-negative1

Birmingham, Alabama1 trial

Testing Whether High Dose Chemotherapy and Infusion of the Patients' Own Stem Cells Improves Survival in Patients With Peripheral T-cell Lymphoma Who Achieved a Complete Response at the End of the Initial Chemotherapy

University of Alabama at Birmingham Cancer Center

Phase 3

Duarte, California1 trial

CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant

City of Hope Medical Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.